About this event
Join Eliaz Therapeutics Founder & CEO, Dr. Isaac Eliaz, for a live investor webinar on August 6 at 7:00 PM ET (4:00 PM PT).
Dr. Eliaz will share the latest company and campaign updates since our July investor webinar, discuss how investor capital is expected to support upcoming product development milestones, and answer your questions during a live Q&A.
Whether you're attending for the first time or joining us again, you'll learn more about the current investment opportunity, fundraising progress, the science behind XGal-3® and its investigational approach to targeting Galectin-3 in sepsis, Eliaz Therapeutics' portfolio of 75 patents across 30+ countries, progress toward upcoming clinical trials and hospital integration, and the potential future role of XGal-3® in cancer research.
